Innate immune mechanisms in the liver

Liver Immunology: Principles and Practice

Volumn , Issue , 2007, Pages 41-48

  O'Farrelly, Cliona ^a,b   Doherty, Derek G ^c  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650106955     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-518-3_4     Document Type: Chapter

References (57)

1. Medzhitov R, Janeway C. Innate immunity. N Engl J Med 2000; 343:338-344
2. Medzhitov R, Janeway C. Decoding the patterns of self and nonself by the innate immune system. Science 2002; 296:298-300
3. Cooper EL, Kauschke E, Cosarizza A. Digging for innate immunity since Darwin and Metchnikoff. BioEssays 2002; 24:319-333
4. Janeway C, Travers P, Walport M, Shlomchik M. Immunobiology, 6th ed. New York, Churchill Livingstone, pp. 37-48
5. Van Oosten M, van Amersfoort ES, van Berkel TJ, Kuiper J. Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J Endotoxin Res 2001; 7:381-384
6. Rowell DL, Eckmann L, Dwinell MB, et al. Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. Am J Physiol 1997; 273: 322-332
7. Wagner S, Lynch NJ, Walter W, Schwaeble WJ, Loos M. Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues. J Immunol 2003; 170: 1462-1465
8. Strey CW, Markiewski M, Mastellos D, et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 2003; 198:913-923
9. Diehl AM. Cytokine regulation of liver injury and repair. Immunol Rev 2000; 174:160-171
10. O'Neill LA. Immunology. After the toll rush. Science 2004; 303:1481-1482
11. O'Neill LA. TLRs: Professor Mechnikov, sit on your hat. Trends Immunol 2004; 25:687-693
12. Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: The Toll-like receptors and their transducers. J Leukoc Biol 2003; 74:479-485
13. Seki E, Tsutsui H, Iimuro Y, et al. Contribution of Toll-like receptor/ myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 2005; 41:443-450
14. Knolle PA, Loser E, Protzer U, et al. Regulation of endotoxininduced IL-6 production in liver sinusoidal endothelial cells and Kupffer cells by IL-10. Clin Exp Immunol 1997; 107:555-561
15. De Creus A, Abe M, Lau AH, Hackstein H, Raimondi G, Thomson AW. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 2005; 174:2037-2045
16. Sanchez-Campillo M, Chicano A, Torio A, et al. Implication of CpG-ODN and reactive oxygen species in the inhibition of intracellular growth of Salmonella typhimurium in hepatocytes. Microbes Infect 2004; 6:813-820
17. Wisse E. Observations on the fine structure and peroxidase cytochemistry of normal rat liver Kupffer cells. J Ultrastruct Res 1974; 46:393-426
18. Wardle EN. Kupffer cells and their function. Liver 1987; 7:63-75
19. Morita A, Itoh Y, Toyama T, et al. Activated Kupffer cells play an important role in intra-hepatic Th1-associated necro-inflammation in Concanavalin A-induced hepatic injury in mice. Hepatol Res 2003; 27:143-150
20. Mosher B, Dean R, Harkema J, Remick D, Palma J, Crockett E. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J Surg Res 2001; 99:201-210
21. Hinglais N, Kazatchkine MD, Mandet C, Appay MD, Bariety J. Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens: An immunohistochemical study. Lab Invest 1989; 61:509-514
22. Ross GD, Vetvicka V. CR3 (CD11b, CD18): A phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin Exp Immunol 1993; 92:181-184
23. Van Egmond M, van Garderen E, van Spriel AB, et al. FcaRI-positive liver Kupffer cells: Reappraisal of the function of immunoglobulin A in immunity. Nat Med 2000; 6:680-685
24. Lentini A, Falasca L, Autuori F, Dini L. The simultaneous exposition of galactose and mannose-specific receptors on rat liver macrophages is developmentally regulated. Biosci Rep 1992; 12:453-461
25. Naito M, Hasegawa G, Takahashi K. Development, differentiation, and maturation of Kupffer cells. Microsc Res Tech 1997; 39:350-364
26. Taniguchi T, Toyoshima T, Fukao K, Nakuchi H. Presence of hematopoietic stem cells in the adult liver. Nat Med 1996; 2: 198-203
27. Watanabe H, Miyaji C, Seki S, Abo, T. c-kit-stem cells and thymocyte precursors in the livers of adult mice. J Exp Med 1996; 184:687-693
28. Crosbie OM, Reynolds M, McEntee G, Traynor O, Hegarty J, O'Farrelly C. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver. Hepatology 1999; 29: 1193-1198
29. Golden-Mason L, Curry M, Nolan N, et al. Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor bearing adult human liver. Hepatology 2000; 31:1251-1256
30. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity? Trends Immunol 2002; 23:445-449
31. Thomson AW, Drakes ML, Zahorchak AF, et al. Hepatic dendritic cells: Immunobiology and role in liver transplantation. J Leukoc Biol 1999; 66:322-330
32. Thomson AW, Lu L. Dendritic cells as regulators of immune reactivity: Implications for transplantation. Transplantation 1999; 68:1-8
33. Thomson AW, Lu L. Are dendritic cells the key to liver transplant tolerance? Immunol Today 1999; 20:27-32
34. Goddard S, Youster J, Morgan E, Adams DH. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 2004; 164:511-519
35. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000; 174:5-20
36. Hata K, Ru Zhang X, Iwatsuki S, Van Thiel D, Herberman R, Whiteside T. Isolation, phenotyping and functional analysis of lymphocytes from human liver. Clin Immunol Pathol 1990; 56: 401-419
37. Hata K, Van Thiel D, Herberman RB, Whiteside T. Natural killer activity of human-derived lymphocytes in various liver diseases. Hepatology 1991; 14:495-503
38. Winnock M, Gacia Barcina M, Lukomska B, et al. Human liver-associated lymphocytes: An overview. J Gastroenterol Hepatol 1995; 10(Suppl 1):S43-S46
39. Doherty DG, Norris S, Madrigal-Estebas L, et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999; 163:2314-2321
40. Lanier LL, Corliss B, Philips JH. Arousal and inhibition of human NK cells. Immunol Rev 1997; 155:145-154
41. Takii Y, Hashimoto S, Iiai T, Watanabe H, Hatakeyama K, Abo T. Increase in the proportion of granulated CD56+ T cells in patients with malignancy. Clin Exp Immunol 1994; 97:522-527
42. Winnock M, Garcia-Barcina M, Huet S, et al. Functional characterization of liver-associated lymphocytes in patients with liver metastasis. Gastroenterology 1993; 105:1152-1158
43. Winnock M, Garcia-Barcina M, Bioulac-Sage P, Balabaud C. Liver-associated lymphocytes: Role in tumor defense. Semin Liver Dis 1993; 13:81-92
44. Norris S, Doherty D, Curry M, et al. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Cancer Immunol Immunother 2003; 52:53-58
45. Crotta S, Stilla A, Wack A, et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002; 195:35-41
46. Nattermann J, Nischalke HD, Hofmeister V, et al. The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am J Pathol 2005; 166:443-453
47. Brigl M, Brenner MB. CD1: Antigen presentation and T cell function. Annu Rev Immunol 2004; 22:817-890
48. Kronenberg M. Toward an understanding of NKT cell biology: Progress and paradoxes. Annu Rev Immunol 2005; 23:877-900
49. Hayakawa Y, Godfrey DI, Smyth MJ. a-Galactosylceramide: Potential immunomodulatory activity and future application. Curr Med Chem 2004; 11:241-252
50. Giaccone G, Punt CJ, Ando Y, et al. A phase I study of the natural killer T-cell ligand a-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res 2002; 8:3702-3709
51. Nieda M, Okai M, Tazbirkova A, et al. Therapeutic activation of Va24+Vb11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 2004; 103:383-389
52. Kenna T, Golden-Mason L, Porcelli SA, et al. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J Immunol 2003; 171: 1775-1779
53. Lucas M, Gadola S, Meier U, et al. Frequency and phenotype of circulating Va24/Vb11 double-positive natural killer T cells during hepatitis C virus infection. J Virol 2003; 77:2251-2257
54. Barnaba V, Franco A, Paroli M, et al. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 1994; 152:3074-3087
55. Deignan T, Curry MP, Doherty DG, et al. Decrease in hepatic CD56+ T cells and Va24+ natural killer T cells in chronic hepatitis C viral infection. J Hepatol 2002; 37:101-108
56. Kelly AM, Golden-Mason L, Traynor O, McEntee G, Hegarty JE, O'Farrelly C. Interleukin 12 (IL-12) is increased in tumour bearing human liver and expands CD8+/CD56+ T cells in vitro but not in vivo. Cytokine 2004; 25:273-282
57. Harada N, Shimada M, Okano S, et al. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice. J Immunol 2004; 173:6635-6644